Orpha-Devel Handels und Vertriebs GmbH

• B01 - Agentes antitrombóticos
• TREPOSUVI solution for infusion 1 mg/ml
• TREPOSUVI solution for infusion 10 mg/ml
• TREPOSUVI solution for infusion 2.5 mg/ml
• TREPOSUVI solution for infusion 5 mg/ml
• C07 - Betabloqueantes
• ESMOCARD LYO lyophilisate for solution for infusion 2 500 mg
• ESMOCARD solution for injection 100 mg/10 ml
• H01 - Hormonas hipofisiarias, hipotalámicas y análogos
• EMBESIN solution for injection 40 IU/2 ml
• N02 - Analgésicos
• LAPAINOL solution for injection 10 mg/1 ml
• V03 - Todos los demás preparados terapéuticos
• NALOXONE ORPHA-DEVEL solution for injection 400 µg/ml